IMS Capital Management Takes $219,000 Position in DENTSPLY SIRONA Inc. $XRAY

IMS Capital Management acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 2nd quarter, Holdings Channel.com reports. The institutional investor acquired 13,800 shares of the medical instruments supplier’s stock, valued at approximately $219,000.

Several other institutional investors have also modified their holdings of XRAY. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at approximately $25,000. Brooklyn Investment Group bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in DENTSPLY SIRONA during the 1st quarter valued at $26,000. Caitong International Asset Management Co. Ltd boosted its holdings in DENTSPLY SIRONA by 8,003.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 2,241 shares during the period. Finally, MassMutual Private Wealth & Trust FSB boosted its holdings in DENTSPLY SIRONA by 160.2% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 2,805 shares of the medical instruments supplier’s stock valued at $45,000 after acquiring an additional 1,727 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Trading Down 0.7%

Shares of NASDAQ:XRAY opened at $12.87 on Thursday. The business’s 50-day moving average is $14.27 and its 200 day moving average is $14.86. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $27.44. The firm has a market capitalization of $2.57 billion, a P/E ratio of -2.72, a P/E/G ratio of 0.81 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. During the same period in the prior year, the company posted $0.49 EPS. The firm’s quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.0%. DENTSPLY SIRONA’s dividend payout ratio is currently -13.50%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on XRAY shares. Stifel Nicolaus dropped their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a report on Friday, August 8th. Barrington Research lowered their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. Wells Fargo & Company lowered their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a report on Friday, August 8th. Finally, UBS Group lowered their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average target price of $18.64.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.